fda bans compounded tirzepatide Ban on GLP-1 Drugs: What to Know FDA Clarifies Compounding Rules as
Description
Exciting news to start the year!We'repleased to announce our DCP submission for Semaglutidewill take placeon February 13th, 2026. Semaglutide is a transformative therapy for adults with type 2 diabetes, improvingglycemiccontrol and weight management
Unflavored powder that mixes seamlessly into any beverage or supplement
Janet Klein, MS RDN, CDN, CDCES, Bariatric Surgery and Obesity Medicine Program Director
The best nutrition plan is simple: focus on whole, minimally processed foods rich in protein, fiber, and healthy fats
